Showing results (2351-2360 of 7,557) with videos related to
Sort By:
Pageof 756
Molecular Pharmaceutics|January 15, 2019
Evaluation Efficacy of Rhenium-188-Loaded Micro-particles for Radiotherapy in a Mouse Model of Hepatocellular CarcinomaYing-Hsia Shih, Cheng-Liang Peng, Mao-Feng Weng, et al.Molecular Pharmaceutics|January 23, 2019
Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast CancerYuqing Sun, Xuqian Li, Lili Zhang, et al.Molecular Pharmaceutics|November 30, 2018
Dynamic Properties of Novel Excipient Suggest Mechanism for Improved Performance in Liquid Stabilization of Protein BiologicsJoshua S Katz, Abigail Nolin, Benjamin A Yezer, et al.Molecular Pharmaceutics|March 8, 2018
Influence of Polymer and Drug Loading on the Release Profile and Membrane Transport of TelaprevirLaura I Mosquera-Giraldo, Na Li, Venecia R Wilson, et al.Molecular Pharmaceutics|March 8, 2018
PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in VitroTania F Bahamondez-Canas, Hairui Zhang, Frederic Tewes, et al.Molecular Pharmaceutics|December 31, 2019
Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation ApproachesPreyanthiny Kirubakaran, Ke Wang, Ian Rosbottom, et al.Molecular Pharmaceutics|December 17, 2019
Antibody Fragment F(ab')2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and RetentionQing Li, Norman Peterson, Richard N Hanna, et al.Molecular Pharmaceutics|December 13, 2019
Extracellular-Matrix-Anchored Click Motifs for Specific Tissue TargetingMary R Adams, Christopher T Moody, Jennifer L Sollinger, et al.Molecular Pharmaceutics|December 13, 2019
Evaluation of an Integrin αvβ3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer ImagingYongkang Gai, Yaqun Jiang, Yu Long, et al.Molecular Pharmaceutics|December 14, 2019
Clinically Relevant OATP2B1 Inhibitors in Marketed Drug SpaceMelissa S Unger, Jennypher Mudunuru, Matthias Schwab, et al.Pageof 756